Re: J. Alfred Witjes, Thierry Lebret, Eva M. Comperat, et al. Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer. Eur Urol 2017; 71: 462-75

被引：2

作者：

Bokarica, Pero ^{[1
]}

Hrkac, Adelina ^{[1
]}

Gilja, Ivan ^{[1
]}

机构：

[1] Clin Hosp Sveti Duh, Dept Urol, Sveti Duh 64, Zagreb 10000, Croatia

来源：

EUROPEAN UROLOGY | 2017年 / 72卷 / 02期

关键词：

D O I：

10.1016/j.eururo.2017.02.031

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E45 / E45

页数：1

共 44 条

[31] Re: Helena Vila-Reyes, G. Joel DeCastro, and James M. McKiernan's Letter to the Editor re: Yunjin Bai, Yubo Yang, and Yin Tang's Letter to the Editor re: Andrea Necchi, Marco Bandini, Giuseppina Calareso, et al. Multiparametric Magnetic Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer: Preliminary Findings from the PURE-01 Study. Eur Urol 2020; 77:636-43. Eur Urol 2020;77:e158: Can mpMRI Replace Conventional Transurethral Resection of Bladder Cancer? Eur Urol 2021;79:e35-e36
Panebianco, Valeria
Del Giudice, Francesco
Narumi, Yoshifumi
Simone, Giuseppe
De Berardinis, Ettore
Catto, Jamed W. F.
EUROPEAN UROLOGY, 2021, 79 (02) : E52 - E53
[32] Reply to Gopa Iyer, Bernard H. Bochner, Eliezer M. Van Allen, David B. Solit, and Jonathan E. Rosenberg's Letter to the Editor re: Russell EN Becker, Alexa R. Meyer, Aaron Brant, et al. Clinical Restaging and Tumor Sequencing are Inaccurate Indicators of Response to Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.07.016
Becker, Russell E. N.
Baras, Alex
Bivalacqua, Trinity J.
EUROPEAN UROLOGY, 2021, 79 (02) : E58 - E59
[33] Reply to Christian Daniel Fankhauser, Lorelei A. Mucci, and Travis A. Gerke's Letter to the Editor re: Won Sik Ham, Heather J. Chalfin, Zhaoyong Feng, et al. New Prostate Cancer Grading System Predicts Long-term Survival Following Surgery for Gleason Score 8-10 Prostate Cancer. Eur Urol 2017;71:907-12
Epstein, Jonathan I.
Trock, Bruce
Han, Misop
EUROPEAN UROLOGY, 2017, 72 (01) : E11 - E12
[34] Reply to Donald Lamm, Andreas Bohle, Joan Palou, et al.'s Letter to the Editor re: Per-Uno Malmstrom, Richard J. Sylvester, David E. Crawford, et al. An Individual Patient Data Meta-Analysis of the Long-Term Outcome of Randomised Studies Comparing Intravesical Mitomycin C versus Bacillus Calmette-Guerin for Non-Muscle-Invasive Bladder Cancer. Eur Urol 2009;56:247-56
Malmstrom, Per-Uno
Sylvester, Richard J.
EUROPEAN UROLOGY, 2010, 57 (02) : E10 - E11
[35] Reply to Stephen B. Williams and Ashish M. Kamat's Letter to the Editor re: Samantha Cambier, Richard J. Sylvester, Laurence Collette, et al. EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non-Muscle-invasive Stage Ta-T1 Urothelial Bladder Cancer Patients Treated with 1-3 Years of Maintenance Bacillus Calmette-Guerin. Eur Urol 2016;69:60-9
Sylvester, Richard
Gontero, Paolo
Oddens, Jorg
EUROPEAN UROLOGY, 2016, 69 (06) : E123 - E124
[36] Reply to Rodolfo Montironi, Liang Cheng, Marina Scarpelli, Alessia Cimadamore, Francesco Montorsi, and Antonio Lopez-Beltran's Letter to the Editor re: Gillian Vandekerkhove, Werner J. Struss, Matti Annala, et al. Circulating Tumor DNA Abundance and Potential Utility in De Novo Metastatic Prostate Cancer. Eur Urol 2019; 75:667-75: How Does Circulating DNA Reach the Blood Stream?
Wyatt, Alexander W.
Chi, Kim N.
Gleave, Martin E.
EUROPEAN UROLOGY, 2019, 76 (03) : E73 - E74
[37] Re: Samantha Cambier, Richard J. Sylvester, Laurence Collette, et al. EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non-Muscle-invasive Stage Ta-T1 Urothelial Bladder Cancer Patients Treated with 1-3 Years of Maintenance Bacillus Calmette-Guerin. Eur Urol 2016;69:60-9
Williams, Stephen B.
Kamat, Ashish M.
EUROPEAN UROLOGY, 2016, 69 (06) : E121 - E122
[38] Reply to Joanne L. Dickinson, Georgea R. Foley, and Liesel M. FitzGerald's Letter to the Editor re: Daniel J. Lee, Ryan Hausler, Anh N. Le, et al. Association of Inherited Mutations in DNA Repair Genes with Localized Prostate Cancer. Eur Urol 2022;81:559-67. Red Flags in Association Analyses for Rare Variants
Lee, Daniel J.
Hausler, Ryan
Maxwell, Kara N.
EUROPEAN UROLOGY, 2022, 82 (06) : E170 - E171
[39] Reply to Mustafa Aldemir and Abdullah Erdem Canda's Letter to the Editor re: Per-Uno Malmstrom, Richard J. Sylvester, David E. Crawford, et al. An Individual Patient Data Meta-Analysis of the Long-Term Outcome of Randomised Studies Comparing Intravesical Mitomycin C versus Bacillus Calmette-Guerin for Non-Muscle-Invasive Bladder Cancer. Eur Urol 2009;56:247-56
Malmstrom, Per-Uno
Sylvester, Richard
EUROPEAN UROLOGY, 2010, 58 (02) : E24 - E25
[40] Reply to Eliezer M. Van Allen, Levi A. Garraway and Jonathan E. Rosenberg's Letter to the Editor re: Floris H. Groenendijk, Jeroen de Jong, Elisabeth E. Fransen van de Putte, et al. ERBB2 Mutations Characterize a Subgroup of Muscle-invasive Bladder Cancers with Excellent Response to Neoadjuvant Chemotherapy. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.01.014
Groenendijk, Floris H.
van de Putte, Elisabeth E. Fransen
van Rhijn, Bas W. G.
Bernards, Rene
van der Heijden, Michiel S.
EUROPEAN UROLOGY, 2015, 68 (02) : E33 - E34

← 1 2 3 4 5 →